Gérard Emilien, Cécile Durlach, Kenneth L. Minaker, Bengt Winblad, Serge Gauthier, Jean-Marie Maloteaux

Alzheimer Disease (eBook, PDF)

Neuropsychology and Pharmacology

• Format: PDF

Produktbeschreibung

Alzheimer disease (AD) has become the most common form of dementia in industrialized countries and represents an increasing burden at the economic, social and medical level. In discussing both the biological aspects of AD as well as the cognitive functions involved, Alzheimer Disease - Neuropsychology and Pharmacology presents a comprehensive picture of the pathology and approaches to diagnosis and treatment. Basic research including animal models, molecular and genetic aspects is also taken into consideration. In part I, the biological correlates of AD are discussed. In part II the neuropsychological aspects such as cognitive impairment, loss of functional autonomy and emergence of neuropsychiatric disturbances of AD are outlined. In part III, strategies for effective treatment and prevention of AD are discussed. This book will be a useful source of information for clinicians as well as researchers in the area of neuropharmacology.

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: Birkhäuser Basel
• Seitenzahl: 288
• Erscheinungstermin: 6. Dezember 2012
• Englisch
• ISBN-13: 9783034878425
• Artikelnr.: 53123551

Autorenporträt

Cécile Durlach, Paris, France / Serge Gauthier, McGill Centre for Studies in Aging, Verdun, QC, Canada / Jean-Marie Maloteaux, Université Catholique de Louvain, Belgium

Inhaltsangabe

I: Biological correlates of Alzheimer disease.- 1: Alzheimer disease.- 2: Neurological dysfunctions in Alzheimer disease.- 3: Pharmacology of Alzheimer disease.- 4: Molecular genetics of Alzheimer disease.- 5: Promises of animal models of Alzheimer disease.- II: Neuropsychology of Alzheimer disease.- 6: What is memory?.- 7: Mild cognitive impairment.- 8: Cognitive impairment in Alzheimer disease.- 9: Behavioral and psychological impairments.- 10: Assessment of memory.- 11: Functional abilities and behavioral symptom assessments.- III: Treatment of Alzheimer disease.- 12: Pharmacological treatments of cognitive deficits.- 13: Pharmacological treatment of neuropsychiatric symptoms.- 14: Psychological support and cognitive rehabilitation.- 15: Discussion and conclusion.- References.